2019 - Fellow, National Academy of Inventors
His primary areas of investigation include Molecular biology, T-cell receptor, T cell, Antigen and Major histocompatibility complex. His Molecular biology research incorporates themes from CTL*, Cytotoxic T cell, CD8, Gene and Antibody. His studies deal with areas such as Yeast display, Peptide sequence, Cell biology, Clone and Peptide as well as T-cell receptor.
A large part of his T cell studies is devoted to MHC restriction. The study incorporates disciplines such as Protein structure and Transfection in addition to Antigen. His research integrates issues of Complementarity determining region and Docking in his study of Major histocompatibility complex.
His primary scientific interests are in T-cell receptor, Molecular biology, Major histocompatibility complex, T cell and Antigen. He has researched T-cell receptor in several fields, including Receptor, CD8, Peptide and Cell biology. The concepts of his Cell biology study are interwoven with issues in Superantigen and Affinity maturation.
His studies examine the connections between Molecular biology and genetics, as well as such issues in Cytotoxic T cell, with regards to Clone. His Major histocompatibility complex study incorporates themes from Complementarity determining region, Peptide sequence and Yeast display. His Antigen study integrates concerns from other disciplines, such as Cell culture and Immune system.
His scientific interests lie mostly in T-cell receptor, T cell, Antigen, Major histocompatibility complex and Cell biology. His T-cell receptor research includes elements of Cytotoxic T cell, Receptor, Peptide and Directed evolution. His work focuses on many connections between T cell and other disciplines, such as Gene, that overlap with his field of interest in In vivo and Transmembrane protein.
Antigen is a subfield of Immunology that David M. Kranz explores. His work carried out in the field of Major histocompatibility complex brings together such families of science as Protein structure and Complementarity determining region. Within one scientific family, he focuses on topics pertaining to Yeast display under Cell biology, and may sometimes address concerns connected to Affinity maturation and Microbiology.
His primary scientific interests are in T-cell receptor, Immunology, Cell biology, Antigen and T cell. His study in T-cell receptor is interdisciplinary in nature, drawing from both Cytotoxic T cell and Major histocompatibility complex. His Major histocompatibility complex research is multidisciplinary, relying on both Protein structure and Peptide.
His work deals with themes such as Cancer, Cancer research and Disease, which intersect with Immunology. His study looks at the intersection of Cell biology and topics like Receptor with Genetically modified organism, Function and Binding site. His research in T cell intersects with topics in CD8 and Immunotherapy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells
Mercedes B. Fuertes;Aalok K. Kacha;Justin Kline;Seng Ryong Woo.
Journal of Experimental Medicine (2011)
Positive and negative selection of an antigen receptor on T cells in transgenic mice
William C. Sha;Christopher A. Nelson;Rodney D. Newberry;David M. Kranz.
Nature (1988)
Complete primary structure of a heterodimeric T-cell receptor deduced from cDNA sequences.
Haruo Saito;David M. Kranz;Yohtaroh Takagaki;Adrian C. Hayday.
Nature (1984)
APRIL: a processor architecture for multiprocessing
Anant Agarwal;Beng-Hong Lim;David Kranz;John Kubiatowicz.
international symposium on computer architecture (1990)
A third rearranged and expressed gene in a clone of cytotoxic T lymphocytes.
Haruo Saito;David M. Kranz;Yohtaroh Takagaki;Adrian C. Hayday.
Nature (1984)
The MIT Alewife machine: architecture and performance
Anant Agarwal;Ricardo Bianchini;David Chaiken;Kirk L. Johnson.
international symposium on computer architecture (1995)
Structure, organization, and somatic rearrangement of T cell gamma genes
Adrian C. Hayday;Haruo Saito;Stephen D. Gillies;David M. Kranz.
Cell (1985)
Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma.
Avery D. Posey;Robert D. Schwab;Alina C. Boesteanu;Catharina Steentoft.
Immunity (2016)
Quantitative Analysis of the Contribution of TCR/pepMHC Affinity and CD8 to T Cell Activation
Phillip D. Holler;David M. Kranz.
Immunity (2003)
T-cell receptor binding affinities and kinetics: impact on T-cell activity and specificity.
Jennifer D. Stone;Adam S. Chervin;David M. Kranz.
Immunology (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
MIT
MIT
University of Chicago
University of Wisconsin–Madison
MIT
MIT
Stanford University
Fred Hutchinson Cancer Research Center
University of Maryland, College Park
University of Iowa
Macquarie University
Institut National de la Recherche Scientifique
Carnegie Mellon University
Tsinghua University
National Research Council (CNR)
Hunan University
Beijing Normal University
British Trust for Ornithology
University of Tsukuba
Oregon State University
National Centre for Biological Sciences
University of Pennsylvania
University of Southern California
University of Cambridge
Leipzig University
London School of Hygiene & Tropical Medicine